About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Discover the top ReFa/Ro dividend stocks for September 2025 with high yields and analyst-backed returns. Click for the picks.
Apple (AAPL) and Formula 1 entered a five-year partnership to bring all F1 races exclusively to Apple TV in the U.S. from ...
Pokémon Legends: Z-A is out now across Nintendo Switch and Nintendo Switch 2, and sees the introduction of a new real-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback